Healthcare has had a tumultuous past two years.
What will the next two years look like? Will we still be discussing the pandemic impact?
Two help answer these questions, our very own Mark Dorner, co-founder and CEO of PreciseMDX, recently shared his predictions with Health IT Answers on the continued impact the demand for a consumer-centric diagnostic testing experience will have on both patients and clinical labs in 2022:
“The COVID-19 pandemic impacted the way all healthcare stakeholders provide services and care. As the call for testing became critical, clinical labs were counted on to dramatically ramp up operations, create new processes, and provide on-demand testing for millions of consumers. This scramble exposed a need in the healthcare industry for an automated diagnostic testing experience so that labs can scale rapidly, patients can have control over the process and receive results quickly, and providers can treat patients quicker with a faster, more connected system.”
“Now, as we look to a post-pandemic way of life, the impact that testing procedures have on our lives is here to stay – and it goes far beyond COVID. Certainly, COVID-19 testing will continue to remain a priority, but labs will need to invest in advanced platforms that support all types of diagnostic testing including women’s and men’s health (fertility, prenatal, cancer, testosterone), sexual health (STIs, HPV, UTI), wellness/nutrition (nutrition DNA kit, food allergy/intolerances), respiratory, nail fungal wound panels, and more.”
“Labs must continue to efficiently bring testing – that supports many types – to patients where, when and how they are most convenient. As a result, in 2022, I expect labs will partner across a variety of channels including retail, direct to consumer and on-premises vending machines as they look to transform the diagnostic testing experience to one that is automated, simple, and user friendly. That’s exactly what healthcare consumers expect.”
Co-Founder and CEO
To read the full article, visit Health IT Answers.